Wound Care Biologics Market Size, Share, Growth, Emerging Trends, Top 10 Players and Industry Outlook

Wound Care Biologics Market Size, Share, Growth, Emerging Trends, Top 10 Players and Industry Outlook

This report aims to provide detailed insights into the global wound care biologics market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

[123 Pages Report] The wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.29 Billion in 2017 at a CAGR of 9.8%.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=259878425

Key Factors Driving Market Growth:

Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market.

The biological skin substitutes segment is estimated to account for the largest share of the wound care biologics market in 2018.

On the basis of product, the market is bifurcated into biological skin substitutes and topical agents. In 2018, the biological skin substitutes segment is expected to account for the largest share of the wound care biologics market. The large share of this segment can be attributed to the rising incidence of diabetes and the subsequent growth in the demand for chronic wound care products across the globe.

Ulcers are anticipated to account for the largest share of the wound care biologics market in 2018.

The three major categories of wounds included in this market are ulcers (including pressure, diabetic foot, venous, and other ulcers), surgical & traumatic wounds, and burns. The ulcers segment is expected to dominate the market in 2018. This segment is also expected to grow at the highest CAGR during the forecast period. Market growth is largely driven by the significantly higher prevalence of diabetic foot ulcers and venous leg ulcers as compared to surgical & traumatic wounds and burns.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=259878425

North America is expected to command the largest share of the market in 2018.

In this report, the wound care biologics market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share the global market. The large share of the North American market can primarily be attributed to the high prevalence of venous leg ulcers and diabetic foot ulcers and the strong presence of major market players in this region.

Key Players:

Key players in the wound care biologics market include Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US).



Contact:
Mr. Ashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441